Volume 45 ()
The Regulation of Medical Innovation and Pharmaceutical Markets
Tomas J. Philipson
Health Insurance and the Growth in Pharmaceutical Expenditures
Patricia Danzon and Mark V. Pauly
The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the U.S. Pharmaceuticals Industry
Frank R. Lichtenberg and Tomas J. Philipson
Direct-to-Consumer Advertising and the Demand for Cholesterol-Reducing Drugs
John E. Calfee, Clifford Winston, and Randolph Stempski
Deregulating Direct-to-Consumer Marketing of Prescription Drugs: Effects on Prescription and Over-the-Counter Product Sales
Davina C. Ling, Ernst R. Berndt, and Margaret K. Kyle